North America: Food, Drugs, Healthcare, Life Sciences

The landscape of pharmacy regulation in Ohio continues to evolve, and pharmacies licensed in the state should pay close attention to the Ohio State Board of Pharmacy’s latest proposed rulemaking. On July 1, 2026...

This month, the U.S. Food & Drug Administration (“FDA”) quietly published its Unified Agenda, which includes a proposed rulemaking that — if finalized — would fundamentally reshape the landscape...

Nevada pharmacies, physicians, healthcare facilities and other practitioners engaged in pharmaceutical compounding should closely monitor a significant regulatory proposal issued by the Nevada State Board of Pharmacy.

Effective August 25, 2026, Ohio House Bill 377 will revise the law governing light-based medical devices used for hair removal. The law modifies physician delegation standards related to hair removal lasers and creates specific provisions for advanced practice registered nurse and physician assistant delegation.

For years, long-term care providers have navigated the delicate balance between respecting resident privacy, accommodating family oversight, honoring roommate privacy, and maintaining smooth facility operations.

The US Department of Labor has proposed a new electronic disclosure safe harbor specifically for ERISA-covered group health plans, potentially transforming how plan administrators deliver required disclosures to participants. This proposed framework would mirror the 2020 retirement plan e-disclosure safe harbor by enabling default electronic delivery through a notice-and-access model, moving away from the outdated 2002 consent-based standard. The DOL projects this change could raise electronic delivery rate

On July 22, 2026, the Food and Drug Administration (FDA) announced two additional steps in its ongoing effort to phase out petroleum-based color additives from the U.S. food supply.

The landscape of pharmacy regulation in Ohio continues to evolve, and pharmacies licensed in the state should pay close attention to the Ohio State Board of Pharmacy’s latest proposed rulemaking. On July 1, 2026...

This month, the U.S. Food & Drug Administration (“FDA”) quietly published its Unified Agenda, which includes a proposed rulemaking that — if finalized — would fundamentally reshape the landscape...